₹1,357.15 8.20 (0.61%)
10:07 AM, 13-Dec-2024₹1,355.20 9.70 (0.72%)
09:54 AM, 13-Dec-2024BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
Last Updated: 13-Dec-2024 | 10:07 AM IST
Market Cap (₹ Cr) | 25,708 |
Traded Value (₹ Cr) | 0.04 |
Volume (Shares) | 317 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,577.50 |
52-Week High Date | 18-Sep-2024 |
52-Week Low (₹) | 1,226.50 |
52-Week Low Date | 13-Aug-2024 |
All Time High (₹) | 1,577.50 |
All Time High Date | 18-Sep-2024 |
All Time Low (₹) | 1,226.50 |
All Time Low Date | 13-Aug-2024 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 25,672 |
EPS - TTM (₹) [C] | 30.30 |
P/E Ratio (X) [C] | 44.73 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | 0.21 |
Book Value Share (₹) [C] | 217.42 |
P/B Ratio (₹) [C] | 6.23 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Nippon India Multi Cap Fund (G) | 136.50 | 10,00,000 | 0.35 |
Nippon India Multi Cap Fund (IDCW) | 136.50 | 10,00,000 | 0.35 |
Nippon India Multi Cap Fund (B) | 136.50 | 10,00,000 | 0.35 |
Nippon India Multi Cap Fund - Direct (G) | 136.50 | 10,00,000 | 0.35 |
Nippon India Multi Cap Fund - Direct (B) | 136.50 | 10,00,000 | 0.35 |
Nippon India Multi Cap Fund - Direct (IDCW) | 136.50 | 10,00,000 | 0.35 |
Aditya Birla SL ELSS Tax Saver Fund (IDCW) | 57.08 | 4,18,179 | 0.36 |
Aditya Birla SL ELSS Tax Saver Fund (G) | 57.08 | 4,18,179 | 0.36 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) | 57.08 | 4,18,179 | 0.36 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) | 57.08 | 4,18,179 | 0.36 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 1,343.00 1,358.75 |
Week Low/High (₹) | 1,336.10 1,391.00 |
Month Low/High (₹) | 1,278.00 1,443.00 |
Year Low/High (₹) | 1,225.00 1,580.00 |
All time Low/High (₹) | 1,226.50 1,580.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -1.18% | -1.00% | -1.16 | -1.23% |
1 Month | 1.60% | 1.63% | 3.95 | 3.46% |
3 Month | -4.61% | -4.72% | -2.57 | -3.88% |
6 Month | % | % | 5.14 | 4.16% |
1 Year | % | % | 16.06 | 16.47% |
3 Year | % | % | 38.57 | 40.33% |
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & CEO : SATISH RAMANLAL MEHTA
Chairman & Independent Directo : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Non Executive Director : Samonnoi Banerjee
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Company Sec. & Compli. Officer : CHETAN RAJENDRA SHARMA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 1,357.15 at 10:07 AM IST on 13th Dec 2024. Emcure Pharmaceuticals Ltd share price was up by 0.61% over the previous closing price of Rs 1,348.95. Emcure Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 25,708 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,577.50 and 52-week low share price is Rs 1,226.50.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 86.92 crore on a total income of Rs 1,159.56 crore for the quarter ended 2024. For the year ended Sep 2024, Emcure Pharmaceuticals Ltd had posted a profit of Rs 201.55 crore on a total income of Rs 2,037.64 crore.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Gland Pharma, J B Chemicals &, Natco Pharma, Emcure Pharma, Pfizer, Concord Biotech, Wockhardt.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows: